Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.15%
1,084.19
-1.62
-0.15%
—1,085.811,083.231,084.341,074.08——
SIXC
Communications
SIXC
Communications
SIXC
+0.25%
609.21
+1.52
+0.25%
—607.69607.69609.89604.02——
SIXE
Energy
SIXE
Energy
SIXE
+0.18%
1,194.48
+2.10
+0.18%
—1,192.381,200.061,206.851,186.65——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.36%
1,750.06
-6.33
-0.36%
—1,756.391,753.531,753.531,733.52——
SIXM
Financials
SIXM
Financials
SIXM
-0.28%
631.56
-1.71
-0.28%
—633.27631.36633.90628.75——
SIXR
Staples
SIXR
Staples
SIXR
+0.10%
853.23
+0.81
+0.10%
—852.42853.25856.20851.06——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.14%
219.09
+0.30
+0.14%
—218.79218.79219.14217.26——
SIXT
Technology
SIXT
Technology
SIXT
+0.81%
3,741.61
+29.92
+0.81%
—3,711.693,719.293,746.513,699.88——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.48%
906.66
-4.39
-0.48%
—911.05909.99913.34906.52——
SIXV
Health care
SIXV
Health care
SIXV
+1.45%
1,522.41
+21.75
+1.45%
—1,500.661,504.161,526.631,504.16——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.04%
2,453.92
-1.04
-0.04%
—2,454.962,450.632,456.502,435.72——
4195:TPE
Genomics Bioscience & Technology Co Ltd
NT$16.70
-0.89%
(-0.15) 1D
May 28, 1:30:32 PM GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 4195...
Open
NT$16.85
High
NT$17.50
Low
NT$16.65
Mkt. cap
1.21B
Avg. vol.
344.69K
Volume
554.78K
52-wk high
NT$22.85
52-wk low
NT$16.65
EPS
-NT$0.75
No. of employees
115
News stories
From sources across the web
About Genomics Bioscience & Technology Co Ltd
CEO-
Employees115
Founded1984
Headquarters-
SectorBiotechnology
Websitegenomics.com.tw
Previous reportsAll values in TWD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in TWD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
155.15M
178.00M
220.06M
151.79M
Cost of goods sold
99.38M
128.05M
150.21M
107.39M
Cost of revenue
99.38M
128.05M
150.21M
107.39M
Research and development expenses
19.43M
20.69M
22.95M
20.72M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
55.18M
56.48M
56.64M
57.38M
Operating expense
75.14M
81.94M
83.29M
75.38M
Total operating expenses
174.53M
209.98M
233.50M
182.77M
Operating income
-19.37M
-31.98M
-13.44M
-30.98M
Other non operating income
-523.50K
-204.00K
132.00K
-12.77M
EBT including unusual items
-19.30M
2.49M
-31.53M
-47.79M
EBT excluding unusual items
-21.29M
-36.37M
-16.72M
-47.79M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-12.06M
9.52M
-24.83M
-39.07M
Net profit margin
-7.77%
5.35%
-11.28%
-25.74%
Earnings per share
-
-
-
-0.54
Interest and investment income
616.00K
228.00K
650.00K
235.00K
Interest expense
-3.29M
-3.48M
-3.64M
-4.28M
Net interest expenses
-2.67M
-3.25M
-2.99M
-4.04M
Depreciation and amortization charges
-
-
-
-
EBITDA
-4.60M
-15.55M
4.03M
-10.20M
Gain or loss from assets sale
-1.45M
19.00K
-
-95.00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer